4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-25-022455
SVP, Head of Finance & Admin. sold 2,488 shares at $13.95 ($34,708)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William SVP, Head of Finance & Admin. | 2025-02-18 | Sale 10b5-1 | −2,488 | $13.95 | $34,708 | 124,590 | D: show line 1 in the form |
| Open-market sales · 2,488 sh · avg $13.95 · $34,708 | |||||||
Loading xslF345X05/ownership.xml…